Limula
PrivateLast Round
Debt
Dec 11, 2024
Total Funding Raised
$15.43M
Company Overview
Limula is a biotechnology company that develops an automated, closed-system platform for the manufacturing of personalized cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limula Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Limula Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 11, 2024 | ||||
| Seed | May 21, 2024 | ||||
| Grant | Oct 5, 2023 | ||||
| Grant | Jun 21, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
Grant | Oct 11, 2022 |
Key People
Founding team and executive leadership
Limula Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeX Ventures | Seed |
| European Innovation Council | Grant |
| Foundation for Technological Innovation | Debt, Grant |
| Verve Ventures | Seed |
| LifeX Ventures | Seed |
| W.A. de Vigier Foundation | Seed |
| Swiss State Secretariat for Education, Research and Innovation (SERI) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2026
Limula SA is developing an automated Cell and Gene Therapy manufacturing platform.
- Jun 18, 2025
Oliver Dick joins the Strategic Advisory Board.
Limula Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Limula's valuation, stock price, and market status.